JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Quantitative and qualitative metrics of tumor stroma in predicting ovarian cancer outcomes and expansion of its study with AI-based tools

  • 0Masonic Cancer Center and Department of Obstetrics, Gynecology and Women's Health, University of Minnesota, Minneapolis, MA 55455, USA.
Molecular Therapy. Oncology +

|

June 17, 2025

|

June 17, 2025

View abstract on PubMed

Summary

This summary is machine-generated.

Tumor stroma characteristics, including density and texture, offer new prognostic insights for epithelial ovarian cancer. Artificial intelligence can help measure these stromal properties to improve patient outcomes.

Area Of Science

  • Gynecologic Oncology
  • Medical Imaging
  • Biomarker Discovery

Background

  • Epithelial ovarian cancer has poor survival due to late diagnosis and treatment resistance.
  • Current prognostic markers like CA-125 and BRCA status are insufficient for predicting outcomes.
  • Tumor stroma plays a significant, yet underutilized, role in cancer prognosis.

Purpose Of The Study

  • To review the prognostic significance of quantitative and qualitative tumor stroma metrics in epithelial ovarian cancer.
  • To explore the application of artificial intelligence (AI) in measuring stromal properties.
  • To propose a framework for integrating stromal biomarkers into clinical decision-making.

Main Methods

  • Literature review of studies examining tumor stroma characteristics (proportion, density, stiffness, texture).
  • Analysis of how AI tools can quantify these stromal parameters.
  • Synthesis of evidence on the prognostic value of stromal metrics.

Main Results

  • Stromal proportion, density, stiffness, and texture are emerging as critical prognostic indicators.
  • AI enables advanced, quantitative measurement of these stromal features.
  • Integrating stromal metrics with existing biomarkers may enhance predictive accuracy.

Conclusions

  • Tumor stroma metrics offer a promising avenue for improved prognostic assessment in ovarian cancer.
  • AI-powered analysis of stromal properties can significantly advance clinical decision-making.
  • Further research and integration of these novel biomarkers are crucial for enhancing patient survival rates.

Keywords: